Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes
L Poirel, A Jayol, P Nordmann - Clinical microbiology reviews, 2017 - Am Soc Microbiol
Polymyxins are well-established antibiotics that have recently regained significant interest
as a consequence of the increasing incidence of infections due to multidrug-resistant Gram …
as a consequence of the increasing incidence of infections due to multidrug-resistant Gram …
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …
Background Antimicrobial-resistant infections are commonly encountered in US hospitals
and result in significant morbidity and mortality. This guidance document provides …
and result in significant morbidity and mortality. This guidance document provides …
International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical …
BT Tsuji, JM Pogue, AP Zavascki… - … : The Journal of …, 2019 - Wiley Online Library
The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the
1950s and thus did not undergo contemporary drug development procedures. Their clinical …
1950s and thus did not undergo contemporary drug development procedures. Their clinical …
[PDF][PDF] Infectious Diseases Society of America antimicrobial resistant treatment guidance: gram-negative bacterial infections
The rise in antimicrobial resistance (AMR) continues to be a global crisis [1, 2]. Collectively,
antimicrobial resistant pathogens caused more than 2.8 million infections and over 35,000 …
antimicrobial resistant pathogens caused more than 2.8 million infections and over 35,000 …
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas …
JC Hamrick, JD Docquier, T Uehara… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
As shifts in the epidemiology of β-lactamase-mediated resistance continue, carbapenem-
resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa …
resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa …
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
This article provides a comprehensive review of currently available treatment options for
infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance …
infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance …
[HTML][HTML] Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options
The first decade of the 20th century witnessed a surge in the incidence of infections due to
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
Polymyxin: alternative mechanisms of action and resistance
MJ Trimble, P Mlynárčik… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Antibiotic resistance among pathogenic bacteria is an ever-increasing issue worldwide.
Unfortunately, very little has been achieved in the pharmaceutical industry to combat this …
Unfortunately, very little has been achieved in the pharmaceutical industry to combat this …